Skip to main content
. 2013 Jul 24;2(7):e59. doi: 10.1038/psp.2013.33

Figure 1.

Figure 1

Metabolic lability of sirolimus in recombinant P450 and FMO enzymes. Sirolimus (3 µmol/l) was incubated with recombinant drug-metabolizing enzymes. P450 concentration was set at 50 pmol/ml. Protein concentration of recombinant FMO enzyme was set at 0.5 and 1.0 mg/ml in pH = 9.5 glycine buffer (a) and pH = 7.4 potassium phosphate buffer (b), respectively. Data represent the mean of duplicate determinations.